Local control of locally advanced (N2) non-small cell lung cancer: when and how?
作者信息
Park Byung Jo, Kim Jhingook
机构信息
Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
出版信息
J Thorac Dis. 2019 May;11(Suppl 9):S1169-S1171. doi: 10.21037/jtd.2019.04.26.
Abstract
摘要
相似文献
1
Local control of locally advanced (N2) non-small cell lung cancer: when and how?局部晚期（N2）非小细胞肺癌的局部控制：时机与方式？
J Thorac Dis. 2019 May;11(Suppl 9):S1169-S1171. doi: 10.21037/jtd.2019.04.26.
2
Role of surgery in N2 NSCLC: pros.手术在N2期非小细胞肺癌中的作用：优势
Jpn J Clin Oncol. 2016 Dec;46(12):1168-1173. doi: 10.1093/jjco/hyw125. Epub 2016 Sep 21.
3
Minimal invasive surgery in locally advanced N2 non-small cell lung cancer.局部晚期N2非小细胞肺癌的微创手术
Transl Lung Cancer Res. 2021 Jan;10(1):519-528. doi: 10.21037/tlcr.2020.03.27.
4
The role of docetaxel in N2 locally advanced non-small-cell lung cancer.
Clin Lung Cancer. 2005 Dec;7 Suppl 3:S87-92. doi: 10.3816/clc.2005.s.016.
5
[Standards, options and recommendations for the management of locally advanced non small cell lung carcinoma].[局部晚期非小细胞肺癌管理的标准、选择和建议]
Bull Cancer. 2001 Apr;88(4):369-87.
6
[Neo-adjuvant chemotherapy of locally advanced non-small cell bronchial cancers].[局部晚期非小细胞支气管癌的新辅助化疗]
Rev Pneumol Clin. 1994;50(4):147-54.
7
Role of multimodality therapy in cIIIA-N2 non-small cell lung cancer: perspective.多模态疗法在cIIIA-N2期非小细胞肺癌中的作用：观点
Jpn J Clin Oncol. 2016 Dec;46(12):1174-1178. doi: 10.1093/jjco/hyw131. Epub 2016 Oct 4.
8
Combined-modality treatment of locally advanced non-small cell lung cancer: incorporation of novel chemotherapeutic agents.局部晚期非小细胞肺癌的综合治疗：新型化疗药物的纳入
Chest. 1998 Jan;113(1 Suppl):53S-60S. doi: 10.1378/chest.113.1_supplement.53s.
9
Surgery after chemoradiotherapy in patients with stage III (N2 or N3, excluding T4) non-small-cell lung cancer: a systematic review.放化疗后 III 期（N2 或 N3，不包括 T4）非小细胞肺癌患者行手术治疗：一项系统评价。
Curr Oncol. 2019 Jun;26(3):e398-e404. doi: 10.3747/co.26.4549. Epub 2019 Jun 1.
10
Intraoperative radiation therapy in the multimodality approach to upper aerodigestive tract cancer.多模态治疗上消化道癌中的术中放射治疗
Surg Oncol Clin N Am. 2003 Oct;12(4):1043-63. doi: 10.1016/s1055-3207(03)00089-9.
本文引用的文献
1
Occult stage IIIA-N2 patients have excellent overall survival with initial surgery.隐匿性IIIA-N2期患者接受初始手术后总体生存率良好。
J Thorac Dis. 2018 Dec;10(12):6670-6676. doi: 10.21037/jtd.2018.10.94.
2
Immune checkpoint inhibitors and non-small-cell lung cancer management: 2018 update.免疫检查点抑制剂与非小细胞肺癌治疗：2018年更新
Immunotherapy. 2019 Feb;11(3):149-153. doi: 10.2217/imt-2018-0167.
3
Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC.度伐利尤单抗化疗和放疗后用于 III 期非小细胞肺癌的总生存。
N Engl J Med. 2018 Dec 13;379(24):2342-2350. doi: 10.1056/NEJMoa1809697. Epub 2018 Sep 25.
4
ctDNA and CTCs in Liquid Biopsy - Current Status and Where We Need to Progress.液体活检中的循环肿瘤DNA和循环肿瘤细胞——现状与未来发展方向
Comput Struct Biotechnol J. 2018 Jun 1;16:190-195. doi: 10.1016/j.csbj.2018.05.002. eCollection 2018.
5
Long-term survival in locally advanced non-small cell lung cancer invading the great vessels and heart.局部晚期侵犯大血管和心脏的非小细胞肺癌的长期生存。
Thorac Cancer. 2018 May;9(5):598-605. doi: 10.1111/1759-7714.12625. Epub 2018 Mar 30.
6
Temporal and regional distribution of initial recurrence site in completely resected N1-stage II lung adenocarcinoma: The effect of postoperative adjuvant chemotherapy.完全切除的 N1 期 II 期肺腺癌初始复发部位的时间和区域分布：术后辅助化疗的影响。
Lung Cancer. 2018 Mar;117:7-13. doi: 10.1016/j.lungcan.2018.01.004. Epub 2018 Jan 6.
7
Recurrence dynamics after trimodality therapy (Neoadjuvant concurrent chemoradiotherapy and surgery) in patients with stage IIIA (N2) lung cancer.根治性放化疗（新辅助同期放化疗和手术）后 IIIA 期（N2）肺癌患者的复发动态。
Lung Cancer. 2018 Jan;115:89-96. doi: 10.1016/j.lungcan.2017.11.020. Epub 2017 Nov 22.
8
Upfront surgery as first-line therapy in selected patients with stage IIIA non-small cell lung cancer.对于特定的 IIIA 期非小细胞肺癌患者， upfront 手术作为一线治疗方法。
J Thorac Cardiovasc Surg. 2018 Apr;155(4):1814-1822.e4. doi: 10.1016/j.jtcvs.2017.10.075. Epub 2017 Nov 3.
9
Induction Therapies Plus Surgery Versus Exclusive Radiochemotherapy in Stage IIIA/N2 Non-Small Cell Lung Cancer (NSCLC).
Am J Clin Oncol. 2018 Mar;41(3):267-273. doi: 10.1097/COC.0000000000000416.
10
Stereotactic Body Radiation Therapy as an Alternative to Surgery in Early-Stage Non-Small-Cell Lung Cancer.立体定向体部放射治疗作为早期非小细胞肺癌手术的替代方案
Oncology (Williston Park). 2017 Jun 15;31(6):492-8.
Zotero 插件